States will see a significant reduction in shipments of COVID-19 monoclonal antibody treatments from the federal government beginning March 21 as the White House’s request for $15.6 billion in pandemic funding stalls in Congress, ABC News reported.
Read the full post on Becker's Hospital Review - Healthcare News